Nitric oxide and cancer therapy: the emperor has NO clothes
JR Hickok, DD Thomas - Current pharmaceutical design, 2010 - ingentaconnect.com
The role of nitric oxide (NO•) as a mediator of cancer phenotype has led researchers to
investigate strategies for manipulating in vivo production and exogenous delivery of this …
investigate strategies for manipulating in vivo production and exogenous delivery of this …
[HTML][HTML] Nitric oxide (NO) and NO synthases (NOS)-based targeted therapy for colon cancer
Colorectal cancer (CRC) is one of the most lethal malignancies worldwide and CRC therapy
remains unsatisfactory. In recent decades, nitric oxide (NO)—a free-radical gas—plus its …
remains unsatisfactory. In recent decades, nitric oxide (NO)—a free-radical gas—plus its …
Opportunities for nitric oxide in potentiating cancer immunotherapy
Despite nearly 30 years of development and recent highlights of nitric oxide (NO) donors
and NO delivery systems in anticancer therapy, the limited understanding of exogenous …
and NO delivery systems in anticancer therapy, the limited understanding of exogenous …
Quinone methide bioactivation pathway: contribution to toxicity and/or cytoprotection?
J Louise Bolton - Current organic chemistry, 2014 - ingentaconnect.com
The formation of quinone methides (QMs) from either direct 2-electron oxidation of 2-or 4-
alkylphenols, isomerization of oquinones, or elimination of a good leaving group could …
alkylphenols, isomerization of oquinones, or elimination of a good leaving group could …
Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery
MA Hollas, MB Aissa, SH Lee, JM Gordon-Blake… - Nitric Oxide, 2019 - Elsevier
The development of small molecule modulators of NO/cGMP signaling for use in the CNS
has lagged far behind the use of such clinical agents in the periphery, despite the central …
has lagged far behind the use of such clinical agents in the periphery, despite the central …
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni
S Guglielmo, D Cortese, F Vottero, B Rolando… - European journal of …, 2014 - Elsevier
A series of NO-donor praziquantel hybrid compounds was obtained by combining
praziquantel (PZQ) and furoxan moieties in a single entity. NO-donor properties of the …
praziquantel (PZQ) and furoxan moieties in a single entity. NO-donor properties of the …
Soluble guanylyl cyclase is a critical regulator of migraine-associated pain
Background Nitric oxide (NO) has been heavily implicated in migraine. Nitroglycerin is a
prototypic NO-donor, and triggers migraine in humans. However, nitroglycerin also induces …
prototypic NO-donor, and triggers migraine in humans. However, nitroglycerin also induces …
The latest advances in the discovery of nitric oxide hybrid drug compounds
RAM Serafim, FG Pernichelle… - Expert Opinion on Drug …, 2017 - Taylor & Francis
Introduction: There is a great interest in Nitric oxide (NO) within medicinal chemistry since it's
involved in human signaling pathways. Prodrugs or hybrid compounds containing NO-donor …
involved in human signaling pathways. Prodrugs or hybrid compounds containing NO-donor …
Natural remedies for non‐steroidal anti‐inflammatory drug‐induced toxicity
JP Simon, S Evan Prince - Journal of Applied Toxicology, 2017 - Wiley Online Library
The liver is an important organ of the body, which has a vital role in metabolic functions. The
non‐steroidal anti‐inflammatory drug (NSAID), diclofenac causes hepato‐renal toxicity and …
non‐steroidal anti‐inflammatory drug (NSAID), diclofenac causes hepato‐renal toxicity and …
Prospects of NSAIDs administration as double-edged agents against endometrial cancer and pathological species of the uterine microbiome
O Kuźmycz, P Stączek - Cancer biology & therapy, 2020 - Taylor & Francis
Many types of cancers, including endometrial cancer, were found to have cyclooxygenase-2
(COX-2) overexpression. Because this enzyme belongs to the group of pro-inflammatory …
(COX-2) overexpression. Because this enzyme belongs to the group of pro-inflammatory …